CDK7 and breast carcinoma: Because p53 is a well-known tumor suppressor present in a wide range of cancer cells and modulates the transcription of various downstream genes, we hypothesized that p53 protein level elevation in breast cancer cells possibly presents a viable method of breast cancer treatment via CDK7 inhibition.